NCT00482300已完成不适用
Systematic Pelvic Lymphadenectomy Versus no Lymphadenectomy in Clinical Stage I-II Endometrial Cancer
University of Roma La Sapienza0 个研究点开始时间: 2007年6月5日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
研究概览
简要总结
The purpose of this trial is to determine whether the addition of systematic pelvic lymphadenectomy to hysterectomy with bilateral adnexectomy improves disease-free survival (DFS) and overall survival (OS) in patients with preoperatively supposed Stage I-II endometrial cancer
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- — 至 75 Years（Child, Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Histologically proven endometrioid or adenosquamous endometrial carcinoma.
- •Patients having myometrial invasion
- •Age =/< 75 years
- •Informed consent.
排除标准
- •Serous papillary and clear cell tumors.
- •Karnofsky index < 80 or severe diseases contraindicating surgery
- •Concomitant neoplasia (basalioma cutis excluded)
- •Distant metastasis or abdominal metastasis detected intraoperatively.
- •Absence of myometrial invasion at frozen section.
研究者
相似试验
招募中
不适用
Endometrial Cancer Lymphadenectomy TrialCancer of Endometrium Stage ICancer of Endometrium Stage IINCT03438474Philipps University Marburg640
已完成
不适用
Lymphadenectomy In Ovarian NeoplasmsOvarian CancerNCT00712218Philipps University Marburg640
暂停
3 期
Pelvic and Aortic-cava Lymphadenectomy Randomized for Ovarian CancerOvarian CancerNCT01218490Institut Cancerologie de l'Ouest450
招募中
不适用
Pelvic and Para-aortic Lymphadenectomy in Patients with Stage I or II Endometrial Cancer with High Risk of Recurrence (ECLAT; AGO-OP.6) A Multicenter, Prospective Randomized Controlled TrialKCT0004981niversity Medical Center Gottingen10
招募中
不适用
Endometrial Cancer Lymphadenectomy Trialendometrial cancerJPRN-jRCT1030210303Yabuno Akira15